Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Feedback Regulation of Calcium Concentration01:27

Feedback Regulation of Calcium Concentration

3.4K
Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
3.4K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

719
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
719
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

900
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
900
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

472
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
472
  1. ホーム
  3. Irs2シグナリングは,ca2+ホメオスタシスを維持することによって,ストレス誘発性不律症から保護します.
  1. ホーム
  3. Irs2シグナリングは,ca2+ホメオスタシスを維持することによって,ストレス誘発性不律症から保護します.

関連する実験動画

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

10.1K

IRS2シグナリングは,Ca2+ホメオスタシスを維持することによって,ストレス誘発性不律症から保護します.

Qian Shi1, Jinxi Wang1, Hamza Malik1

  • 1Department of Internal Medicine (Q.S., J.W., H.M., X.L., J. Streeter, J. Sharafuddin, E.W., B.C., D.H., L.-S.S., E.D.A.), Carver College of Medicine, University of Iowa, Iowa City.

Circulation
|September 10, 2024

PubMed で要約を見る

まとめ
この要約は機械生成です。

心臓インスリン受容体基質タンパク質-2 (IRS2) は,カルシウム処理を調節することにより,心律異常から保護します. 心臓細胞におけるIRS2の削除は不律症のリスクを高め,IRS2を心臓疾患の潜在的な治療標的として強調する.

キーワード:
心臓発作カルシウムカルシウムカルモジュリン依存タンパク質キナーゼ2型インスリン受容体基板タンパク質リアノジン受容体のカルシウム放出チャネル

さらに関連する動画

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

1.1K
Monitoring ER/SR Calcium Release with the Targeted Ca2+ Sensor CatchER+
12:30

Monitoring ER/SR Calcium Release with the Targeted Ca2+ Sensor CatchER+

Published on: May 19, 2017

14.8K

関連する実験動画

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

10.1K
Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

1.1K
Monitoring ER/SR Calcium Release with the Targeted Ca2+ Sensor CatchER+
12:30

Monitoring ER/SR Calcium Release with the Targeted Ca2+ Sensor CatchER+

Published on: May 19, 2017

14.8K

科学分野:

  • 心臓病科
  • 分子生物学
  • 遺伝学

背景:

  • インスリン受容体基板タンパク質-2 (IRS2) は,インスリンシグナル伝達および他の経路に不可欠です.
  • IRS2 (cIRS2- KO) の心筋細胞特異的消去は,心臓の圧力過負荷に対する感受性を高めます.
  • 心臓病とストレスへの適応におけるIRS2の役割は完全に理解されていません.

研究 の 目的:

  • 心律不全におけるIRS2の役割を調査する.
  • ストレスに起因する心臓機能障害に対するIRS2介護による保護の仕組みを特定する.
  • アリズム障害の治療対象としてIRS2の可能性を評価する.

主な方法:

  • IRS2変異の患者の電子医療記録の遡及分析
  • cIRS2-KOマウスにおける心律乱症の感受性の検討
  • マウスモデルにおけるコンフォカルカルシウムイメージング,ウエスタン・ブロッティング,および薬理学的/遺伝的介入.

主要な成果:

  • IRS2変異の患者は心律不全のリスクが増加した.
  • cIRS2- KOの心臓はカテキアミンに敏感で,再注血室動脈不全を示した.
  • IRS2の消去は,AKT1/NOS3/CaMKII/RyR2経路の過剰活性化によるサルコプラズマ網膜機能障害とカルシウムの誤用を引き起こした.
  • AKT阻害またはRyR2安定化により,cIRS2-KOマウスの心律異常が回復しました.

    • 結論:

    • 心臓のIRS2は,交感性ストレスによるAKT/ NOS3/ CaMKII/ RyR2過剰活性化およびカルシウム依存性不律化を抑制する.
    • IRS2は,ストレス下での心臓カルシウムホメオスタシスの維持に不可欠です.
    • IRS2シグナリング軸は,抗不律性治療のための新しい標的を表しています.